CRNDE mediates the viability and epithelial–mesenchymal transition of renal cell carcinoma via miR-136-5p

References

• Sheng X, Jin J, He Z, et al. Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies. BMC Cancer. 2020;20(1):219.
   PubMed Web of Science ®Google Scholar
• Cui H, Shan H, Miao MZ, et al. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Sci Rep. 2020;10(1):4271.
   PubMed Web of Science ®Google Scholar
• van Spronsen DJ, de Weijer KJ, Mulders PF, et al. Novel treatment strategies in clear-cell metastatic renal cell carcinoma. Anticancer Drugs. 2005;16(7):709–717.
   PubMed Web of Science ®Google Scholar
• Chen T, You Y, Jiang H, et al. Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017;232(12):3261–3272.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.
   PubMed Web of Science ®Google Scholar
• Wallace MC, Preen D, Jeffrey GP, et al. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765–779.
   PubMed Web of Science ®Google Scholar
• Goyal N, Kesharwani D, Datta M. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. Cell Mol Life Sci. 2018;75(10):1827–1837.
   PubMed Web of Science ®Google Scholar
• Hardin H, Helein H, Meyer K, et al. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs. Lab Invest. 2018;98(9):1133–1142.
   PubMed Web of Science ®Google Scholar
• Shao K, Shi T, Yang Y, et al. Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt/β-catenin signaling in renal cell carcinoma. Tumour Biol. 2016;37(1423-0380):1423–380.
   Google Scholar
• Graham LD, Pedersen SK, Brown GS, et al. Colorectal Neoplasia Differentially Expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer. 2011;2(8):829–840.
   PubMedGoogle Scholar
• Fan YF, Yu ZP, Cui XY. lncRNA Colorectal Neoplasia Differentially Expressed (CRNDE) promotes proliferation and inhibits apoptosis in non-small cell lung cancer cells by regulating the miR-641/CDK6 Axis. Med Sci Monit. 2019;25:2745–2755.
   PubMed Web of Science ®Google Scholar
• Yu B, Du Q, Li H, et al. Diagnostic potential of serum exosomal colorectal neoplasia differentially expressed long non-coding RNA (CRNDE-p) and microRNA-217 expression in colorectal carcinoma. Oncotarget. 2017;8(48):83745–83753.
   PubMedGoogle Scholar
• Grossi V, Hyams JS, Glidden NC, et al. Characterizing clinical features and creating a gene expression profile associated with pain burden in children with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26(8):1283–1288.
   PubMed Web of Science ®Google Scholar
• Xu J, Huang B, Li S, et al. Knockdown of LETM1 inhibits proliferation and metastasis of human renal cell carcinoma cells. Oncol Lett. 2018;16(5):6377–6382.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang Q, Mao J, et al. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Chem Biol Interact. 2018;296:145–153.
   PubMed Web of Science ®Google Scholar
• Lingadahalli S, Jadhao S, Sung YY, et al. Novel lncRNA LINC00844 regulates prostate cancer cell migration and invasion through AR signaling. Mol Cancer Res. 2018;16(12):1865–1878.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang ZJ, Jian WG, et al. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Mol Cancer. 2019;18(1):15.
   PubMedGoogle Scholar
• Liu Y, Fu QZ, Pu L, et al. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells. Mol Med Reports. 2017;16(4):5107–5112.
   PubMed Web of Science ®Google Scholar
• Wang W, Lou W, Ding B, et al. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging (Albany NY)). 2019;11(9):2610–2627.
   PubMedGoogle Scholar
• Liu LJ, Yu JJ, Xu XL. MicroRNA-93 inhibits apoptosis and promotes proliferation, invasion and migration of renal cell carcinoma ACHN cells via the TGF-β/Smad signaling pathway by targeting RUNX3. Am J Trans Res. 2017;9(7):3499–3513.
   PubMed Web of Science ®Google Scholar
• Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res. 2004;10(12 Pt 1):4125–4133.
   PubMed Web of Science ®Google Scholar
• Cheng J, Chen J, Zhang X, et al. Overexpression of CRNDE promotes the progression of bladder cancer. Biomed Pharmacother. 2018;99:638–644.
   PubMed Web of Science ®Google Scholar
• Xie H, Ma B, Gao Q, et al. Long non-coding RNA CRNDE in cancer prognosis: review and meta-analysis. Clinica Chimica Acta. 2018;485:262–271.
   PubMed Web of Science ®Google Scholar
• Yang FY, Wang Y, Wu JG, et al. Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma. Oncol Lett. 2017;14(3):2757–2764.
   PubMed Web of Science ®Google Scholar
• Li TT, Gao X, Gao L, et al. Role of upregulated miR-136-5p in lung adenocarcinoma: a study of 1242 samples utilizing bioinformatics analysis. Pathol Res Pract. 2018;214(5):750–766.
   PubMed Web of Science ®Google Scholar
• Gao RZ, Que Q, Lin P, et al. Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma. Am J Transl Res. 2019;11(11):6754–6774.
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu Y, Chen Q, et al. Long-noncoding RNA colorectal neoplasia differentially expressed gene as a potential target to upregulate the expression of IRX5 by miR-136-5P to promote oncogenic properties in hepatocellular carcinoma. Cell Physiol Biochem. 2018;50(6):2229–2248.
   PubMedGoogle Scholar
• Han C, Fu Y, Zeng N, et al. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Aging (Albany NY)). 2020;12(4):3594–3616.
   PubMedGoogle Scholar
• Xie ZC, Li TT, Gan BL, et al. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Pathol Res Pract. 2018;214(5):644–654.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhao L, Pan X, et al. Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma. Oncol Lett. 2018;15(4):5995–6002.
   PubMed Web of Science ®Google Scholar